Research and Development

The spirit of innovation at Merz Aesthetics can be traced directly back to our company founder, who always started with the question, “What is needed?” The goal behind every new product or formulation was to respond to those needs differently and more successfully, and Merz Aesthetics is proud to continue this tradition today through its highly-specialized research and development programs.

More than 300 Merz employees worldwide focus on innovation and R&D activities, and approximately 100 million euros per year are dedicated to the development of additional products, new formulations and novel indications. Merz’s R&D programs are fully aligned with our global focus on aesthetics and neurotoxins, both of which represent emerging fields with considerable growth potential.

Approximately
300
employees worldwide in R&D
Over EUR
100
million
invested in R&D per year
Global R&D team in
3
locations: Frankfurt, Raleigh, Mesa

Aesthetic medicine

Over the past five years, Merz Aesthetics has successfully completed numerous acquisitions in the medical aesthetics space, bringing in technologies and talent to create a comprehensive aesthetics portfolio of toxins, fillers, energy-based devices and skincare. The development work of our internal R&D teams has enabled Merz Aesthetics to bring to market advanced filler and toxin formulations, new classes of aesthetic devices and indications in all these categories, with much more to come.